92751 ⎘
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
LIPID NANOPARTICLE COMPOSITION
#2Lipid nanoparticle composition
#3KCNQ2-5 CHANNEL ACTIVATOR
#4N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress
#5KCNQ2-5 channel activator
#6SHIP1 modulators and methods related thereto
#7KCNQ2-5 channel activator
#8Hydrogen peroxide-activated compounds as selective anti-cancer therapeutics
#9SHIP1 modulators and methods related thereto
#10N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress
#11N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
#12Benzyloxy anilide derivatives useful as potassium channel modulators
#13Phthalanilate compounds and methods of use
#142-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors
#15Benzyloxy anilide derivatives useful as potassium channel modulators
#16Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
#17Aniline derivatives
#182-Adamantyl derivatives as p2X7 receptor antagonists.